Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Beam Therapeutics (BEAM) Tax Provisions: 2022-2024

  • Beam Therapeutics' Tax Provisions fell 95.64% to $61,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.5 million, marking a year-over-year change of. This contributed to the annual value of $100,000 for FY2024, which is 92.86% down from last year.
  • As of Q4 2024, Beam Therapeutics' Tax Provisions stood at $61,000, which was up 56.41% from $39,000 recorded in Q2 2024.
  • Beam Therapeutics' 5-year Tax Provisions high stood at $2.4 million for Q3 2022, and its period low was $39,000 during Q2 2024.
  • In the last 3 years, Beam Therapeutics' Tax Provisions had a median value of $1.0 million in 2022 and averaged $982,000.
  • Its Tax Provisions has fluctuated over the past 5 years, first surged by 40.00% in 2023, then crashed by 95.64% in 2024.
  • Beam Therapeutics' Tax Provisions (Quarterly) stood at $1.0 million in 2022, then skyrocketed by 40.00% to $1.4 million in 2023, then plummeted by 95.64% to $61,000 in 2024.
  • Its Tax Provisions stands at $61,000 for Q4 2024, versus $39,000 for Q2 2024 and $1.4 million for Q4 2023.